Contrast-enhanced CT-based radiomics model for differentiating risk subgroups of thymic epithelial tumors
Sign Up to like & getrecommendations! Published in 2022 at "BMC Medical Imaging"
DOI: 10.1186/s12880-022-00768-8
Abstract: Background To validate a contrast-enhanced CT (CECT)-based radiomics model (RM) for differentiating various risk subgroups of thymic epithelial tumors (TETs). Methods A retrospective study was performed on 164 patients with TETs who underwent CECT scans… read more here.
Keywords: risk; contrast enhanced; based radiomics; risk subgroups ... See more keywords
Utilizing genomics to identify novel immunotherapeutic targets in multiple myeloma high-risk subgroups
Sign Up to like & getrecommendations! Published in 2025 at "Genome Medicine"
DOI: 10.1186/s13073-025-01503-y
Abstract: Immunotherapy is now standard of care for multiple myeloma, where the most common targets are B cell maturation antigen, CD38, and G protein-coupled receptor class C group 5 member D but strategies to identify additional… read more here.
Keywords: multiple myeloma; utilizing genomics; risk subgroups; high risk ... See more keywords